RRML - Expressions of vascular endothelial cadherin and soluble Fas ligand in patients with viral myocarditis and their correlations
AMLR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Rejection rate (2020): 75%

Română English


Journal Metrics

Impact Factor 0.5
Five Year Impact Factor 0.5
JCI 0.12


Advanced search


Top 10 downloaded articles
- December 2024 -
 
Biomarkers of acute kidney inj... 6
A comprehensive review of glyc... 6
Investigation of cytokine chan... 6
Validation of GOD / PAP method... 4
Romanian Review of Laboratory ... 4
Small patients, big challenges... 3
Expressions of vascular endoth... 3
Role of Th1/Th2 imbalance medi... 3
Recomandările naționale ale ... 3
Towards appropriate training f... 3

Log in

Concept, Design & Programming
Dr. Adrian Man

   
 
Nr. 32(4)/2024 DOI:10.2478/rrlm-2024-0030
XML
TXT

Research article

Expressions of vascular endothelial cadherin and soluble Fas ligand in patients with viral myocarditis and their correlations

Hongmei Hu, Xuejiao Wang, Na Li, Fue Lu, Rui Li

Correspondence should be addressed to: Rui Li

Abstract:

Background: We aimed to explore the expressions of vascular endothelial cadherin (VE-cadherin) and soluble Fas ligand (sFasL) in patients suffering from viral myocarditis (VMC), and the correlations between them. Methods: Fifty VMC patients diagnosed between January 2022 and December 2023 were selected as the subjects (experimental group), and an equal number of participants receiving health examination were included as a control group. The experimental group was then subdivided into mild, moderate, and severe subgroups according to their clinical symptoms. Peripheral blood samples were collected to detect the serum levels of VE-cadherin and sFasL through enzyme-linked immunosorbent assay, and the differences in their levels were compared. The clinical baseline data and cardiac function indicators (left ventricular systolic function as well as early and late left ventricular diastolic function) were acquired. Results: The ejection fraction of the inferior ventricular septum showed no significant difference between the two groups (p>0.05), but there were significant differences in the remaining indicators (p<0.05). The levels of VE-cadherin and sFasL in the experimental group were significantly higher than those in the control group (p<0.05). The severe VMC group had significantly elevated VE-cadherin and sFasL levels compared with those of moderate and mild groups, and the moderate group had significantly raised levels compared to those of the mild group (p<0.05). VE-cadherin level was positively correlated with sFasL level. Conclusions: The elevation of serum VE-cadherin and sFasL levels may be associated with myocardial inflammatory response and cardiac function damage. VE-cadherin and sFasL are potential biomarkers of VMC for early diagnosis and treatment evaluation.

Keywords: correlation, expression, soluble Fas ligand, vascular endothelial cadherin, viral myocarditis

Received: 18.7.2024
Accepted: 8.10.2024
Published: 24.10.2024

 
  PDF Download full text PDF
(669 KB)
     
 
How to cite
Hu H, Wang X, Li N, Lu F, Li R. Expressions of vascular endothelial cadherin and soluble Fas ligand in patients with viral myocarditis and their correlations. Rev Romana Med Lab. 2024;32(4):321-5. DOI:10.2478/rrlm-2024-0030